Ono Pharmaceutical (OPHLY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov20

Ono Pharmaceutical Receives Japanese Approval for BRAF Mutant Colorectal Cancer Therapy

05:35

Oct30

Ono Pharmaceutical released FY2026 Semi-Annual Earnings on October 30 During-Market (EST), actual revenue USD 1.753 B (forecast USD 1.672 B), actual EPS USD 0.1938

20:00

Ono Pharmaceutical released FY2026 Q2 earnings on October 30 During-Market (EST), actual revenue USD 871.96 M (forecast USD 812.99 M), actual EPS USD 0.1069

20:00

Oct22

Ono Pharmaceutical to Release FY2026 Q2 Earnings on October 29 During-Market (EST), Forecast Revenue USD 791.28 M

00:07

Oct18

Ono Pharmaceutical to Present Vimseltinib Efficacy and Safety Data for Tenosynovial Giant Cell Tumor at 2025 European Society for Medical Oncology Congress

13:12

Oct16

Ono Pharmaceutical Attracts Investors' Attention Due to Positive Clinical Trial Results

16:37